第1屆
Display of Difficult Targets
-呈現困難標的的討論會-
2月19日∼20日
由於可能可以獲得結晶構造，對包括離子通道（ion channel）和G蛋白質共軛受容體(CPCR)的膜蛋白質之理解有大幅進展。此外，適應能與膜蛋白質一起使用的噬菌體和酵母之研究亦在進行中。此討論會聚焦於蛋白質的選擇、共結晶化、促效藥（agonist）結合與活性化、以及發現和精製的手法等，令人期待這些手法有助於因應困難標的藥劑之開發。
Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Antibody Engineering, R&D, Lead Discovery, Diagnostics, Therapeutics, Biologics and Chemistry.
Topics will include, but are not limited to:
- Insights from crystal structures of membrane proteins
- Antibody selection against membrane proteins
- Expression and purification of multi-pass proteins
- Locking GPCR conformation with ligands or antibodies
- Strategies for drug development
- Evolution of ligands to membrane proteins
The deadline for submission is July 29, 2011.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
